Hill-Rom Sees Unusually Large Options Volume (NYSE:HRC)

Hill-Rom Holdings, Inc. (NYSE:HRC) was the target of some unusual options trading on Monday. Stock traders bought 1,016 put options on the company. This represents an increase of approximately 1,331% compared to the average volume of 71 put options.

Shares of NYSE:HRC opened at $106.57 on Tuesday. The firm has a 50 day simple moving average of $104.39 and a 200-day simple moving average of $104.06. Hill-Rom has a twelve month low of $81.85 and a twelve month high of $111.63. The company has a current ratio of 1.31, a quick ratio of 1.10 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $7.20 billion, a PE ratio of 20.98, a P/E/G ratio of 1.68 and a beta of 0.82.

Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, November 1st. The medical technology company reported $1.69 EPS for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.04. Hill-Rom had a net margin of 5.24% and a return on equity of 21.67%. The firm had revenue of $782.80 million for the quarter, compared to the consensus estimate of $759.14 million. During the same period last year, the firm posted $1.63 EPS. The company’s revenue was up 3.1% on a year-over-year basis. As a group, equities research analysts predict that Hill-Rom will post 5.52 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be paid a $0.21 dividend. The ex-dividend date is Friday, December 13th. This represents a $0.84 annualized dividend and a yield of 0.79%. Hill-Rom’s dividend payout ratio is presently 16.54%.

In related news, SVP Andreas G. Frank sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $105.83, for a total value of $634,980.00. Following the completion of the transaction, the senior vice president now directly owns 40,004 shares of the company’s stock, valued at $4,233,623.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Deborah Rasin sold 4,739 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $103.97, for a total transaction of $492,713.83. Following the completion of the transaction, the senior vice president now owns 31,001 shares in the company, valued at $3,223,173.97. The disclosure for this sale can be found here. Corporate insiders own 0.73% of the company’s stock.

Hedge funds have recently modified their holdings of the business. BlackRock Inc. boosted its stake in Hill-Rom by 4.9% during the 2nd quarter. BlackRock Inc. now owns 6,649,313 shares of the medical technology company’s stock worth $695,650,000 after purchasing an additional 307,825 shares during the period. Vanguard Group Inc. raised its holdings in shares of Hill-Rom by 2.6% in the second quarter. Vanguard Group Inc. now owns 6,322,476 shares of the medical technology company’s stock valued at $661,458,000 after buying an additional 163,177 shares during the last quarter. Select Equity Group L.P. raised its holdings in shares of Hill-Rom by 79.9% in the third quarter. Select Equity Group L.P. now owns 2,556,189 shares of the medical technology company’s stock valued at $268,988,000 after buying an additional 1,135,168 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Hill-Rom by 3.9% during the second quarter. Invesco Ltd. now owns 1,120,793 shares of the medical technology company’s stock worth $117,257,000 after buying an additional 42,163 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Hill-Rom by 3.9% during the second quarter. Bank of New York Mellon Corp now owns 1,120,643 shares of the medical technology company’s stock worth $117,242,000 after buying an additional 41,997 shares during the period. 82.85% of the stock is currently owned by institutional investors.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: Why Dividend Stocks May Be Right for You

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.